JK Agri Genetics Ltd.

As of June 30, 2026, JK Agri Genetics Ltd. carries a market capitalization of 1.46B, placing it among publicly traded companies globally. Its enterprise value stands at 1.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, JK Agri Genetics Ltd. has 4.64M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.97 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.46B versus a market cap of 1.46B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 7.30M in revenue per employee across its workforce of 205.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, JK Agri Genetics Ltd. recorded 64.27M in income tax expense. The company reported a pretax loss of -21.61M and -85.88M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, JK Agri Genetics Ltd.'s stock has declined approximately 44.67% over the past 52 weeks. The 50-day moving average sits at 288.53, while the 200-day moving average is 322.43.

Over the twelve months ended June 30, 2026, JK Agri Genetics Ltd. generated 1.50B in revenue and converted that into -85.88M in net income, yielding earnings per share of -18.52. EBITDA reached -9.93M, while operating income came in at -34.65M.

Over the twelve months ended June 30, 2026, JK Agri Genetics Ltd. posted a gross margin of 41.82, reflecting its pricing power and cost economics. The operating margin of -2.31 and net profit margin of -5.73 provide insight into operational efficiency.